|
1
|
Taylor LP: Diagnosis, treatment, and
prognosis of glioma: Five new things. Neurology. 75 18 Suppl
1:S28–S32. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gourlay J, Morokoff AP, Luwor RB, Zhu HJ,
Kaye AH and Stylli SS: The emergent role of exosomes in glioma. J
Clin Neurosci. 35:13–23. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Erdem-Eraslan L, Gravendeel LA, de Rooi J,
Eilers PH, Idbaih A, Spliet WG, den Dunnen WF, Teepen JL, Wesseling
P, Smitt Sillevis PA, et al: Intrinsic molecular subtypes of glioma
are prognostic and predict benefit from adjuvant procarbazine,
lomustine, and vincristine chemotherapy in combination with other
prognostic factors in anaplastic oligodendroglial brain tumors: A
report from EORTC study 26951. J Clin Oncol. 31:328–336. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006–2006. Neuro Oncol. 15
Suppl 2:ii1–ii56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sukumari-Ramesh S, Prasad N, Alleyne CH,
Vender JR and Dhandapani KM: Overexpression of Nrf2 attenuates
Carmustine-induced cytotoxicity in U87MG human glioma cells. BMC
Cancer. 15:1182015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu B, Emdad L, Bacolod MD, Kegelman TP,
Shen XN, Alzubi MA, Das SK, Sarkar D and Fisher PB: Astrocyte
elevated gene-1 interacts with Akt isoform 2 to control glioma
growth, survival, and pathogenesis. Cancer Res. 74:7321–7332. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Steeg PS, Camphausen KA and Smith QR:
Brain metastases as preventive and therapeutic targets. Nat Rev
Cancer. 11:352–363. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hegi ME, Diserens AC, Gorlia T, Hamou MF,
de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani
L, et al: MGMT gene silencing and benefit from temozolomide in
glioblastoma. N Engl J Med. 352:997–1003. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reardon DA, Rich JN, Friedman HS and
Bigner DD: Recent advances in the treatment of malignant
astrocytoma. J Clin Oncol. 24:1253–1265. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chu C, Spitale RC and Chang HY:
Technologies to probe functions and mechanisms of long noncoding
RNAs. Nat Struct Mol Biol. 22:29–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Misawa A, Takayama KI and Inoue S: Long
non-coding RNAs and prostate cancer. Cancer Sci. 108:2107–2114.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Meng H, Bai Y and Wang K: Regulation
of lncRNA and its role in cancer metastasis. Oncol Res. 23:205–217.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ramos AD, Attenello FJ and Lim DA:
Uncovering the roles of long noncoding RNAs in neural development
and glioma progression. Neurosci Lett. 625:70–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma B, Gao Z, Lou J, Zhang H, Yuan Z, Wu Q,
Li X and Zhang B: Long noncoding RNA MEG3 contributes to
cisplatininduced apoptosis via inhibition of autophagy in human
glioma cells. Mol Med Rep. 16:2946–2952. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li H, Li Q, Guo T, He W, Dong C and Wang
Y: LncRNA CRNDE triggers inflammation through the
TLR3-NF-κB-Cytokine signaling pathway. Tumour Biol.
39:10104283177038212017.PubMed/NCBI
|
|
17
|
Zhang J, Li Z, Liu L, Wang Q, Li S, Chen
D, Hu Z, Yu T, Ding J, Li J, et al: Long noncoding RNA TSLNC8 is a
tumor suppressor that inactivates the interleukin-6/STAT3 signaling
pathway. Hepatology. 67:171–187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang MH, Lin CL, Zhang JJ, Weng ZP, Hu T,
Xie Q and Zhong XY: Role of PTEN in cholera toxin-induced SWO38
glioma cell differentiation. Mol Med Rep. 7:1912–1918. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zimonjic DB and Popescu NC: Role of DLC1
tumor suppressor gene and MYC oncogene in pathogenesis of human
hepatocellular carcinoma: Potential prospects for combined targeted
therapeutics (review). Int J Oncol. 41:393–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He Y and Liu X: The tumor-suppressor gene
LZTS1 suppresses hepatocellular carcinoma proliferation by
impairing PI3K/Akt pathway. Biomed Pharmacother. 76:141–146. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ganten TM, Haas TL, Sykora J, Stahl H,
Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel
W, et al: Enhanced caspase-8 recruitment to and activation at the
DISC is critical for sensitisation of human hepatocellular
carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic
drugs. Cell Death Differ. 11 Suppl 1:S86–S96. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Islam T and Resat H: Quantitative
investigation of MDA-MB-231 breast cancer cell motility: Dependence
on epidermal growth factor concentration and its gradient. Mol
Biosyst. 13:2069–2082. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Geng R, Tan X, Wu J, Pan Z, Yi M, Shi W,
Liu R, Yao C, Wang G, Lin J, et al: RNF183 promotes proliferation
and metastasis of colorectal cancer cells via activation of
NF-κB-IL-8 axis. Cell Death Dis. 8:e29942017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Massagué J: TGFbeta in cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chu IM, Lai WC, Aprelikova O, El Touny LH,
Kouros-Mehr H and Green JE: Expression of GATA3 in MDA-MB-231
triple-negative breast cancer cells induces a growth inhibitory
response to TGFß. PLoS One. 8:e611252013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Weller M and Fontana A: The failure of
current immunotherapy for malignant glioma. Tumor-derived TGF-beta,
T-cell apoptosis, and the immune privilege of the brain. Brain Res
Brain Res Rev. 21:128–151. 1995. View Article : Google Scholar : PubMed/NCBI
|
